[144] SCHWAB CHARLES CORP SEC Filing
Rhea-AI Filing Summary
Charles R. Schwab filed a notice of intent to sell 32,413 shares of The Charles Schwab Corporation common stock. The planned sale through The Charles Schwab Corporation as broker is listed with an aggregate market value of $3,422,080.27, on the NYSE around 02/10/2026.
The filing states that 32,413 common shares were originally acquired from the issuer on 03/31/1987 in a leveraged buyout. Shares of common stock outstanding were 1,776,936,770 as of the data shown, providing scale versus the company’s total equity base.
Over the prior three months, the notice lists several separate sales of the issuer’s common stock for the account of Charles R. Schwab, including 134,895 shares on 01/26/2026 for gross proceeds of $13,905,834.00 and 146,560 shares on 01/29/2026 for gross proceeds of $15,119,854.00. The signer represents he is not aware of undisclosed material adverse information about the issuer’s current or prospective operations.
Positive
- None.
Negative
- None.
Insights
Form 144 shows founder Charles R. Schwab planning and recently executing sizable share sales, but without context on his remaining stake.
The notice indicates an intent to sell 32,413 common shares of The Charles Schwab Corporation, with an aggregate market value of $3,422,080.27. These shares trace back to a leveraged buyout acquisition on 03/31/1987, highlighting how long-held founder or insider positions can be gradually monetized.
The document also lists multiple recent sales of common stock for Charles R. Schwab’s account over roughly three weeks, such as 134,895 shares sold on 01/26/2026 for gross proceeds of $13,905,834.00 and 96,625 shares on 02/03/2026 for $10,023,530.00. These transactions are sizable in dollar terms, but the excerpt does not state his total holdings, so the relative scale of selling versus his overall ownership is unclear.
The representation that he does not know any undisclosed material adverse information about the issuer’s operations aligns with standard language for such sales. Overall, this is concrete evidence of continued insider share sales, yet the ultimate impact depends on the proportion of his remaining stake and broader corporate developments, which are not detailed here.